
Hans-Joerg Rudloff
Hans-Joerg Rudloff is Chairman of Barclays Capital and serves on the boards of directors of numerous other companies, including the drug manufacturer Novartis and the oil and gas firm Rosneft.
Hans-Joerg Rudloff is Chairman of Barclays Capital and serves on the boards of directors of numerous other companies, including the drug manufacturer Novartis and the oil and gas firm Rosneft.
Less than two months into his second presidency, Donald Trump has imposed sweeping tariffs on America’s three largest trading partners, with much more to come. This strategy not only lacks any credible theoretical foundations; it is putting the US on a path toward irrevocable economic and geopolitical decline.